Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study)
Access
info:eu-repo/semantics/closedAccessDate
2022Author
Bilici, AhmetÖlmez, Ömer Fatih
Sezer, Ahmet
Öksüzoğlu, Berna
Kaplan, Muhammet Ali
Karadurmuş, Nuri
Çubukçu, Erdem
Şendur, Mehmet Ali Nahit
Aksoy, Sercan
Erdem, Dilek
Başaran, Gül
Çakar, Burcu
Şeker, Mesut
Arslan, Çağatay
Sezgin Göksu, Sema
Çiçin, İrfan
Gümüş, Mahmut
Selçukbiricik, Fatih
Harputluoğlu, Hakan
Helvacı, Kaan
Metadata
Show full item recordCitation
Bilici, A., Ölmez, Ö. F., Sezer, A., Öksüzoğlu, B., Kaplan, M. A., Karadurmuş, N. ... Helvacı, K. (2022). Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study). Journal of Clinical Oncology.Abstract
...
WoS Q Kategorisi
Q1Source
Journal of Clinical OncologyVolume
40Issue
16Collections
- Bildiri Koleksiyonu [515]
- WoS İndeksli Yayınlar Koleksiyonu [6465]